Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 470,783 | 859,902 | 732,836 | 673,470 | 662,205 |
| Marketable Securities | 404,695 | 482,756 | 434,122 | 351,958 | 334,473 |
| Receivables | 423,537 | 417,714 | 399,307 | 408,137 | 419,424 |
| Inventories | 572,239 | 588,911 | 598,989 | 605,156 | 622,253 |
| Other current assets | 10,089 | 12,413 | 13,236 | 26,325 | 10,859 |
| TOTAL | $1,990,479 | $2,466,286 | $2,289,093 | $2,175,317 | $2,139,835 |
| Non-Current Assets | |||||
| PPE Net | 511,639 | 476,648 | 482,001 | 482,712 | 491,371 |
| Investments And Advances | 14,387,010 | 16,230,630 | 11,580,390 | 10,503,040 | 9,561,140 |
| Intangibles | 601,282 | 468,989 | 476,768 | 483,680 | 491,413 |
| Other Non-Current Assets | 308,979 | 310,823 | 289,301 | 288,408 | 288,856 |
| TOTAL | $15,808,910 | $17,487,090 | $12,828,460 | $11,757,840 | $10,832,780 |
| Total Assets | $17,799,390 | $19,953,380 | $15,117,560 | $13,933,160 | $12,972,620 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 489 | 1,739 | 1,736 | 1,738 | 1,798 |
| Accounts payable and accrued liabilities | 141,941 | 136,398 | 133,457 | 138,494 | 139,451 |
| Accrued Expenses | 276,986 | 243,946 | 208,888 | 174,889 | 222,875 |
| Other current liabilities | 127,936 | 177,721 | 154,942 | 166,462 | 131,102 |
| TOTAL | $680,938 | $649,916 | $587,052 | $609,892 | $631,536 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,514 | 10,645 | 10,779 | 10,901 | 12,258 |
| Deferred Revenues | 50,852 | N/A | N/A | N/A | 42,468 |
| Other Non-Current Liabilities | 358,129 | 391,109 | 382,656 | 397,196 | 372,099 |
| TOTAL | $3,433,219 | $3,971,086 | $2,935,624 | $2,714,209 | $2,461,142 |
| Total Liabilities | $4,114,157 | $4,621,002 | $3,522,676 | $3,324,101 | $3,092,678 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,932 | 29,918 | 29,773 | 29,764 | 29,844 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 13,525,340 | 15,080,850 | 11,159,470 | 10,245,430 | 9,268,012 |
| Other shareholders' equity | -175,836 | -62,676 | 124,709 | 68,526 | 282,549 |
| TOTAL | $13,685,240 | $15,332,380 | $11,594,880 | $10,609,060 | $9,879,940 |
| Total Liabilities And Equity | $17,799,397 | $19,953,382 | $15,117,556 | $13,933,161 | $12,972,618 |